Steven P. Gelone - 30 Nov 2021 Form 4 Insider Report for Nabriva Therapeutics plc

Role
President and COO, Director
Signature
/s/ J. Christopher Naftzger, by power of attorney
Issuer symbol
N/A
Transactions as of
30 Nov 2021
Net transactions value
-$49.14
Form type
4
Filing time
02 Dec 2021, 17:28:59 UTC
Previous filing
09 Nov 2021
Next filing
08 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NBRV Ordinary Shares Tax liability $49.14 -63 -0.02% $0.7800 366,288 30 Nov 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These ordinary shares were withheld by the Issuer in order to satisfy tax withholding obligations upon the vesting of certain restricted share units.